New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 13, 2014
07:32 EDTHZNP, POZNHorizon Pharma, POZEN announce USPTO Notice of Allowance for VIMOVO
Horizon Pharma (HZNP) announced that POZEN (POZN), has received a Notice of Allowance from the United States Patent and Trademark Office for U.S. patent application number 14/045,156 entitled "Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs" that covers Horizon and POZEN'S U.S. approved product VIMOVO delayed release tablets.
News For HZNP;POZN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 21, 2015
10:01 EDTHZNPOn the Fly: Analyst Initiation Summary
Subscribe for More Information
06:08 EDTHZNPHorizon Pharma initiated with a Buy at Citigroup
Subscribe for More Information
January 15, 2015
10:00 EDTHZNPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:14 EDTHZNPHorizon Pharma initiated with a Buy at UBS
Subscribe for More Information
January 12, 2015
08:22 EDTHZNPHorizon Pharma secures agreement with FDA on ACTIMMUNE primary endpoint
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use